title: What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Bliden
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
mesh_terms: D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation; D000077144:Clopidogrel; D023921:Coronary Stenosis / Q000601:surgery; D003328:Coronary Thrombosis / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine